Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anthony P Conley

Showing results (11-20 of 79) with videos related to

Pageof 8
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 20, 2014
Dramatic response to pazopanib in a patient with metastatic malignant granular cell tumorAnthony P Conley, Stephanie Koplin, Jamie T Caracciollo, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|July 26, 2018
The Importance of Lymphovascular Invasion in Uterine Adenosarcomas: Analysis of Clinical, Prognostic, and Treatment OutcomesMichael J Nathenson, Anthony P Conley, Heather Lin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 29, 2023
The Landscape of Alterations from 1407 Ultra-Rare Sarcomas from the AACR GENIE Database: Clinical ImplicationsRyan A Denu, Justin T Moyers, Mohamed A Gouda, et al.
Cancers|October 23, 2021
Landscape of Immune-Related Markers and Potential Therapeutic Targets in Soft Tissue SarcomaJason Roszik, Lisa Maria Mustachio, John A Livingston, et al.
JAMA Oncology|July 24, 2015
Physician Underestimation of the Risk of Gastrointestinal Stromal Tumor Recurrence After ResectionAnnie Guérin, Medha Sasane, Christopher Hunt Keir, et al.
Current Problems in Cancer|October 17, 2021
Discovery of targeted expression data for novel antibody-based and chimeric antigen receptor-based therapeutics in soft tissue sarcomas using RNA-sequencing: clinical implicationsRoberto Carmagnani Pestana, Jason Roszik, Roman Groisberg, et al.
Diagnostics (Basel, Switzerland)|February 29, 2020
Molecular Imaging with 3'-deoxy-3'[(18)F]-Fluorothymidine (<sup>18</sup>F-FLT) PET/CT for Early Response to Targeted Therapies in Sarcomas: A Pilot StudyKalevi Kairemo, Elmer B Santos, Homer A Macapinlac, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|March 6, 2013
A comparison between patients with gastrointestinal stromal tumours diagnosed with isolated liver metastases and liver metastases plus sarcomatosisSebastian G de la Fuente, Jeremiah L Deneve, Colin M Parsons, et al.
Cancers|September 5, 2019
Unique Aberrations in Intimal Sarcoma Identified by Next-Generation Sequencing as Potential Therapy TargetsJason Roszik, Abir Khan, Anthony P Conley, et al.
Neurosurgical Focus|May 1, 2024
The role of systemic therapy in advanced skull base chordomas: overview of the current state and the MD Anderson protocolMatei A Banu, Shaan M Raza, Misha Amini, et al.
Pageof 8

Showing results (11-20 of 79) with videos related to

Sort By:
Pageof 8
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 20, 2014
Dramatic response to pazopanib in a patient with metastatic malignant granular cell tumorAnthony P Conley, Stephanie Koplin, Jamie T Caracciollo, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|July 26, 2018
The Importance of Lymphovascular Invasion in Uterine Adenosarcomas: Analysis of Clinical, Prognostic, and Treatment OutcomesMichael J Nathenson, Anthony P Conley, Heather Lin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 29, 2023
The Landscape of Alterations from 1407 Ultra-Rare Sarcomas from the AACR GENIE Database: Clinical ImplicationsRyan A Denu, Justin T Moyers, Mohamed A Gouda, et al.
Cancers|October 23, 2021
Landscape of Immune-Related Markers and Potential Therapeutic Targets in Soft Tissue SarcomaJason Roszik, Lisa Maria Mustachio, John A Livingston, et al.
JAMA Oncology|July 24, 2015
Physician Underestimation of the Risk of Gastrointestinal Stromal Tumor Recurrence After ResectionAnnie Guérin, Medha Sasane, Christopher Hunt Keir, et al.
Current Problems in Cancer|October 17, 2021
Discovery of targeted expression data for novel antibody-based and chimeric antigen receptor-based therapeutics in soft tissue sarcomas using RNA-sequencing: clinical implicationsRoberto Carmagnani Pestana, Jason Roszik, Roman Groisberg, et al.
Diagnostics (Basel, Switzerland)|February 29, 2020
Molecular Imaging with 3'-deoxy-3'[(18)F]-Fluorothymidine (<sup>18</sup>F-FLT) PET/CT for Early Response to Targeted Therapies in Sarcomas: A Pilot StudyKalevi Kairemo, Elmer B Santos, Homer A Macapinlac, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|March 6, 2013
A comparison between patients with gastrointestinal stromal tumours diagnosed with isolated liver metastases and liver metastases plus sarcomatosisSebastian G de la Fuente, Jeremiah L Deneve, Colin M Parsons, et al.
Cancers|September 5, 2019
Unique Aberrations in Intimal Sarcoma Identified by Next-Generation Sequencing as Potential Therapy TargetsJason Roszik, Abir Khan, Anthony P Conley, et al.
Neurosurgical Focus|May 1, 2024
The role of systemic therapy in advanced skull base chordomas: overview of the current state and the MD Anderson protocolMatei A Banu, Shaan M Raza, Misha Amini, et al.
Pageof 8